Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation United ...
Tag: Therapeutics
Roche to acquire cell therapy maker Poseida Therapeutics in US$1.5 billion deal
SWITZERLAND’S Roche will acquire its US collaboration partner Poseida Therapeutics in a cash deal worth up to US$1.5 billion, banking ...
Harpoon Therapeutics Remains Volatile After Promising News
MarketBeat.com - MarketBeat Biotech stocks are often among the market’s most volatile, and Harpoon Therapeutics Inc. (NASDAQ: HARP) offers a ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.